CXCL1 and neoplasm: Plasma CXCL1 levels fail to be a biomarker; however, our results confirmed that tumor-derived STK11 plays a pivotal role in regulating cytokine secretion, thereby contributing to the modulation of the tumor–immune microenvironment.